Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.
暂无分享,去创建一个
Dan Zou | Ye Zhang | X. Che | Yunpeng Liu | X. Qu | K. Hou | Yizhe Wang | Xuejun Hu | Hongfei Yan | Yang Chen | Jie Wu | Yi Yang | M. Deng | Yang Cheng | Mingming Deng | Ye Zhang